More recently, reduced expression of SOD2 has been seen in multiple myeloma cells (Hodge et al, 2005b), androgen-independent prostate cancer (Best et al, 2005; Venkataraman et al, 2005), and invasive breast carcinoma (Soini et al, 2001). This evidence concerns the gene SOD2 and AL amyloidosis.